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CHAPTER 31
Selenoproteins in parasites
Gustavo Salinas
Cátedra de Inmunología, Facultad de Química-Facultad de Ciencias, Universidad de la 
República. Instituto de Higiene, Avda. A. Navarro 3051, Montevideo, CP 11600, Uruguay
Alexey V. Lobanov & Vadim N. Gladyshev
Department of Biochemistry, University of Nebraska–Lincoln, Lincoln, NE 68588-0664, USA
Summary: Parasites, which cause an enormous burden in the population of the third 
world, are a diverse group of organisms, many of which are sensitive to oxidative 
stress imposed by their hosts. In recent years, several selenoprotein families, some 
with antioxidant properties, have been described and characterized in metazoan par-
asites. Glutathione peroxidase and thioredoxin glutathione reductase (TGR) appear to 
be essential selenoproteins in fl atworms (phylum Platyhelminthes). TGR is the single 
enzyme that provides reducing equivalents to both thioredoxin and glutathione path-
ways, in contrast to hosts, which evolve parallel pathways. In roundworms (phylum 
Nematoda), selenoproteins have recently been described, revealing species differences 
in the Sec/Cys protein sets and the presence of an unusual SECIS element. Plasmo-
dium sp, one of the most important protozoan parasites that affect humans, also de-
code Sec. The selenoprotein families encoded by Plasmodial genomes have neither 
Sec nor Cys homologs in their hosts, raising the possibility that targeting their seleno-
proteomes may provide new treatment strategies.
Introduction
Although signifi cant research efforts have been made to study selenoproteins 
and selenocysteine insertion systems in humans and various model organ-
isms, little has been reported in the literature regarding the utilization of se-
lenium in eukaryotic parasitic organisms. This chapter focuses on the prog-
ress made in the characterization of selenoenzyme families in fl atworms, the 
recent advances in the synthesis and utilization of selenoproteins in round-
worms and protozoan parasites, and discusses why selenoproteins of platy-
helminths and plasmodia may represent interesting targets for chemo- or 
immune-prophylaxis.
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Parasites: diverse organisms that face similar oxidative stress challenges
Parasites live at least part of their lifecycle inside another organism (the host), 
which they exploit for their own survival and reproduction. This defi nition 
includes different types of infectious agents (viruses, bacteria, fungi, proto-
zoa, helminths). However, for historical reasons, the term is most often re-
served for ‘protozoa’ and ‘helminths’ organisms. Indeed, parasitology was 
identifi ed as a separate research fi eld during the exploration of the tropics and 
the establishment of ‘tropical medicine’ [1]. Both ‘protozoa’ and ‘helminths’ 
also include free-living organisms, and neither ‘protozoa’ nor ‘helminths’ are 
monophyletic; on the contrary, both groups are represented by highly diver-
gent phyla. Nonetheless, this historical classifi cation is not useless. These two 
groups of parasites are very different: protozoan are unicellular protists, which 
multiply quickly within the host, and are, in most cases, intracellular in habi-
tat; in contrast, helminths are metazoan organisms with complex multicellular 
organization (with nervous system and reproductive organs), which undergo 
complex metamorphoses and migrations within the host. Table 1 presents the 
main features of the major human parasitic infections.
In spite of the diversity of parasites, all face similar biological problems that 
relate to their parasitic lifestyle. Among them, the neutralization of the effector 
mechanisms deployed by the host immune system is of paramount importance. 
Resident macrophages and infl ammatory-site phagocytic leukocytes (mostly 
neutrophils, but also monocytes and eosinophils, depending of the type of in-
fection) are cells equipped to kill foreign organisms. They possess an oxidase 
system located in their plasma membrane, which becomes activated upon cer-
tain stimuli, for example, by interaction of cell receptors with antibodies bound 
to the foreign organism or with parasite molecular motifs (Figure la) [3]. Sub-
sequently, ‘respiratory burst’ (increase in oxygen uptake not linked to respira-
tion) takes place and produces superoxide anion and additional reactive oxy-
gen species (ROS) [4]. Large amounts of nitric oxide (·NO) are also produced 
by macrophages (and to a lesser extent by neutrophils) activated by a variety of 
immunological stimuli, such as y-interferon and tumor necrosis factor. ·NO re-
acts with superoxide to produce peroxynitrite and other reactive nitrogen spe-
cies (RNS) (Figure 1b) [5]. In addition, activated neutrophils and eosinophils 
release myeloperoxidase and eosinophil peroxidase, respectively, that catalyze 
the conversion of hydrogen peroxide and halides into hypohalous acids that are 
powerful oxidants and can form further damaging species [4].
Collectively, ROS and RNS are powerful oxidants and nitrating species: 
they can inactivate enzymes and initiate the process of lipid peroxidation and 
nitration, which leads to radical chain reactions that further damage mem-
branes, nucleic acids and proteins (Figure 1c). These processes (and an addi-
tional arsenal of the host effector cells, such as hydrolytic enzymes) may ul-
timately lead to killing parasitic organisms. Yet, well-adapted parasites cope 
Table 1. Major human parasites (Source: [2])
Protozoan parasitesb
Species (Disease)              Phylum Death per year/DALYsa
Plasmodium sp                    Apicomplexa 1,124,000/42,280,000
(Malariac)
Trypanosoma brucei                Kinetoplastida 50,000/1,590,000
(sleeping sicknessd )
Trypanosoma cruzi                  Kinetoplastida 13,000/649,000
(Chagas diseasee)
Leishmania sp                       Kinetoplastida 59,000/2,357,000
(Leishmaniasisf)
Helminths parasitesg 
Species/Disease Phylum        Death per year/DALYs 
Schistosoma sp Plathyhelminthes  15,000/1,760,000
(Schistosomiasis or bilharziag)
Onchocerca volvulus                Nematoda 0/987,000
(Onchocerciasis or river blindnessh)
Filariidae family                    Nematoda 0/5,644,000
(Lymphatic fi lariasisi)
a DALYs: Disability Adjusted Life Years (the number of healthy years of life lost due to pre-
mature death and disability).
b Protozoan parasites include many diverse phyla, among them Apicomplexa and 
Kinetoplastida.
c Distribution: mainly confi ned to poorer tropical areas of Africa, Asia and Latin America. 
More than 90% of malaria cases and the great majority of malaria deaths occur in tropical 
Africa. Plasmodium falciparum is the main cause of severe clinical malaria and death.
d Distribution: 36 countries in sub-Saharan Africa 
e Distribution: Latin America
f Distribution: Endemic in 88 countries on 4 continents. Two forms of the disease: cutaneous 
(caused by Leishmania major), and visceral (caused by L. donovani)
g Helminth parasites are contained in three phyla: Nematoda (roundworms), Platyhelminthes 
(fl atworms) and Acantocephala (spiny-headed worms). Helminth infections are rarely fa-
tal, but pose an enormous burden to human population in the tropics Distribution: en-
demic in 74 developing countries with more than 80% of infected people living in sub-
Saharan Africa
h Distribution: 35 countries in total. 28 in tropical Africa, where 99% of infected people live. 
Isolated foci in Latin America and Yemen.
i Distribution: Endemic in over 80 countries in Africa, Asia, South and Central America and 
the Pacifi c Islands. Three species are of signifi cance, Wuchereria bancrofti, Brugia ma-
layi, and Brugia timori.
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with the oxidative stress imposed by the host’s immune response by a series 
of cellular chemicals and antioxidant enzymes that directly neutralize ROS 
and RNS (Figure Id), and constitute important model organisms to study an-
tioxidant defense. Several antioxidant enzymes found in parasites belong to 
selenoprotein families.
Glutathione peroxidase: the fi rst selenoenzyme described in parasites
Glutathione peroxidase was the fi rst selenoenzyme to be characterized from 
a parasite. A cDNA from the platyhelminth Schistosoma mansoni encoding 
a GPx with a TGA in-frame at the active site was cloned in the early 1990s 
[6]. The protein encoded by this gene has biochemical properties similar to 
mammalian phospholipid hydroperoxide glutathione peroxidase (PHGPx); 
its activity being higher with phosphatidyl choline hydroperoxide and other 
phospholipid hydroperoxides than with hydroperoxide substrates, such as 
cumene hydroperoxide and hydrogen peroxide [7]. GPx and superoxide dis-
mutase, another antioxidant enzyme, co-localize in the tegument and gut ep-
ithelium of adult worms, which are the exposed interfaces of the parasite to-
wards the host [8]. Additional evidence suggests that antioxidant enzymes, 
and GPx in particular, are vital for ROS neutralization and parasite survival 
within the host. Indeed, expression of GPx is developmentally regulated, 
Figure 1. Reactive oxygen and nitrogen species generated by the host immune re-
sponse and antioxidant defenses, (a) Recognition of parasites by host leukocytes (such 
as macrophages, neutrophils and eosinophils) occurs by pattern recognition receptors 
(PRR) that bind to pathogen-associated molecular patterns (PAMPs), or through anti-
bodies (Ig), and leads to activation of host immune cells. Upon activation, these cells 
produce superoxide (·O2
–) and nitric oxide (·NO) radicals. ·NO is produced in the cyto-
sol (but can cross membranes) by inducible nitric oxide synthase (iNOS); ·O2
– is pro-
duced by a multi-component, membrane-associated NADPH oxidase. Superoxide is 
released towards the extracellular space in the case of non-phagocytosable parasites 
(e.g., worms), or towards the phagosome (topologically equivalent to the extracellu-
lar space) in the case of intracellular parasites (e.g., protozoans). (b) ·NO and ·O2
– re-
act at diffusible controlled rate to produce peroxynitrite (ONOO–). Peroxynitrite can 
react in one-electron oxidations (e.g., with transition metal centers), two electrons ox-
idations (of a given target), or with CO2, redirecting its reactivity. It also decomposes 
spontaneously into other ROS and RNS such as ·OH and ·NO2. In addition, activated 
neutrophils and eosinophils release myeloperoxidase and eosinophil peroxidases, re-
spectively, which catalyze the conversion of hydrogen peroxide and halides into hy-
pohalous acids. (c) Collectively, these products can inactivate enzymes, damage mem-
branes and nucleic acids, and ultimately kill the parasitic organisms. (D) Parasites’ 
defenses include antioxidant enzymes that directly scavenge superoxide, decreasing 
peroxynitrite formation (superoxide dismutases), and hydrogen and organic peroxide 
reductases (GPx and TPx). Some TPx have also been shown to reduce peroxynitrite 
catalytically. Repair mechanisms include methionine sulfoxide reductase, thioredoxin, 
and sulfi redoxin among others. *R’H denotes a hydrocarbon chain, or alcohol (R’H = 
ROH), or a thiol R’H = RSH)
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with the highest levels present in the adult worm [8], the stage most resis-
tant to oxidative stress and immune elimination [9]. In addition, GPx ex-
pression is upregulated by hydrogen peroxide and xanthine/xanthine oxi-
dase generated ROS [10].
Recently, a search for GPx in Expressed Sequence Tag databases (dbEST) 
of platyhelminths identifi ed a second GPx (GPx2) in S. mansoni and S. japon-
icum [11]. GPx2 also encodes a Sec residue at the active site and possesses an 
N-terminal signal peptide, which targets this isoform to the extracellular com-
partment, suggesting that this secreted variant would be important for extra-
cellular hydroperoxide removal, helping to protect the parasite in its immedi-
ate environment. In this study, a GPx1 ortholog whose 3’-untranslated region 
revealed the presence of a SECIS element was also identifi ed in Echinococcus 
granulosus (another fl atworm) transcriptome using the SECISearch algorithm 
(Chapter 9 and http://genome.unl.edu/SECISearch.html) [12].
In contrast to platyhelminths, the corresponding Cys-containing enzymes 
appear to occur in nematodes [13], as reviewed in [14]. Nevertheless, recent 
data-mining of nematode dbEST revealed some exceptions (see below) [15]. 
Free-living nematode Caenorhabditis elegans has no Sec-containing GPx en-
coded in its genome [15].
GSH- and Trx-reduction pathways in platyhelminth parasites are 
controlled by a single selenoenzyme
In most living organisms, there are two analogous and mutually supporting 
enzymic systems that provide antioxidant defense to cells: the glutathione 
(GSH) and the thioredoxin (Trx) systems (Figure 2) [16,17]. These systems 
have overlapping yet distinct targets. GSH, due to its reactivity and intracel-
lular concentration, is one of the most important cellular antioxidants, being 
effi cient in rescuing small disulfi de molecules and in reacting directly with 
ROS. The major function of Trx is to maintain cysteine residues in substrate 
proteins in the reduced form. In addition to their direct function as antioxi-
dants, GSH and Trx provide electrons to GPx and Trx peroxidase (TPx), re-
spectively, which reduce hydrogen peroxide and organic hydroperoxides, and 
to methionine sulfoxide reductase, which is also an important antioxidant re-
pair enzyme. GSH and Trx are usually reduced by GSH and Trx reductases 
(GR and TR), respectively, at the expense of NADPH oxidation.
Recent characterization of these systems in platyhelminth parasites has 
shown that ‘conventional’ GR and TR are absent; instead, the GSH and Trx 
systems are intermingled with the enzyme thioredoxin glutathione reductase 
(TGR), which provides reducing equivalents to both pathways (Figure 2).
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This protein is a second selenoenzyme family that has been character-
ized in platyhelminth parasites (reviewed in [11]). TGR is an oxidoreductase 
shown to possess TR, GR and Grx activities, achieving its broad substrate 
specifi city by a fusion between Grx and TR domains (Figure 2b); this domain 
fusion was originally described in a mouse testis TGR [18].
Experimental and in silico data support the proposition that TGR is the sin-
gle enzyme responsible for recycling both oxidized Trx and GSH in platyhel-
minth parasites. Treatment of S. mansoni adult worm extracts with aurano-
fi n, a known inhibitor of Sec-containing TRs, resulted in complete inhibition 
of TR and GR activities [19]. In addition, TGR was the single protein isolated 
from Taenia crassiceps (also a fl atworm) extracts as a result of tracing GR 
and TR activities [20]. Examination of EST databases from Schistosoma spe-
cies, which covers more than 90% of the gene content of this organism [21], 
revealed cDNAs encoding TGR, but not conventional TR or GR [11]. The 
biochemical characterization of E. granulosus and T. crassiceps TGR indi-
cated that the native enzyme shuttles electrons from NADPH to oxidized Trx 
(TR activity), GSSG (GR activity) and glutathione-mixed disulfi des (Grx ac-
tivity). The stoichiometric inhibitory effect of auranofi n on both GR and TR 
activities of TGR indicates that the Sec-containing C-terminal redox center 
participates in electron transfer to GSSG and oxidized Trx [20,22]. In addi-
tion, TR and Grx domains can function either in coupled reactions or inde-
pendently. Conventional TRs neither bind GSH nor possess GR activity; thus, 
the N-terminal Grx domain of TGR would reduce GSSG, accepting electrons 
from the Sec-containing C-terminal redox center. The idea that the C-terminal 
redox center donates electrons to the fused Grx domain implies that the Grx 
domain of TGR would be linked to the TR domains by a fl exible hinge to al-
low reduction of the oxidized Trx (Figure 2c). It is interesting to note that T. 
crassiceps TGR showed a hysteretic behavior in enzymatic assays with GSSG 
at high concentrations; this observation led the authors to propose a model 
in which TGR would possess high and low affi nity sites for glutathione [20]. 
Clearly, further biochemical characterization and structural data on this multi-
functional enzyme are needed that will shed light on the mechanism of catal-
ysis. In addition, molecular characterization of the corresponding gene could 
also provide clues regarding the mechanism of generation of isoforms. In-
deed, the analysis of TGR in E. granulosus revealed two trans-spliced cDNAs 
derived from a single gene [22]. These variants code for mitochondrial (mt) 
and cytosolic (c) TGRs, containing identical Grx and TrxR domains, but dif-
fering in their N-termini. These variants derive from alternative initiation of 
transcription, followed by trans-splicing. Similarly, mtTGR and cTGR vari-
ants also derived from a single gene have been identifi ed in S. mansoni [11].
Collectively, the results from platyhelminth studies strongly suggest that 
TGR is the main pyridine-nucleotide thiol-disulfi de oxidoreductase in these 
organisms, in contrast to their hosts, where there is some redundancy of mech-
anisms for recycling oxidized Trx and GSH.
Very little has been published about these pathways in the other phylum of 
helminth parasites (Nematoda), and to the best of our knowledge, nothing is 
known about Sec/Cys-containing TR or TGR in parasitic nematodes. How-
ever, no single genome has yet been completed from metazoan parasites.
Selenoproteins of nematode parasites: old families, unusual SECIS
An in silico analysis of Caenorhabditis elegans and Caenorhabditis brigg-
sae (free-living nematodes) genomes revealed that these organisms encode a 
single a selenoprotein, TR [15], corroborating earlier experimental data [23]. 
However, no experimental studies have yet been performed with Selenopro-
teins from parasitic nematodes. Nevertheless, in a recent study [15], the exist-
ing nematode ESTs were searched for selenoprotein genes using SECISearch 
and by screening for homologs of known Selenoproteins. These analysis iden-
tifi ed selenoprotein homologs of selK, selT, selW, Sep15, selenophosphate 
synthetase and GPx. Two interesting points were noted from these analyses. 
First, various nematodes encode different selenoproteins, and the distribution 
of selenoprotein families within this phylum is mosaic. Second, it was found 
that all detected nematode selenoprotein genes contained an unusual form of 
SECIS element, with G rather than a canonical A at the conserved position 
preceding the quartet of non-Watson-Crick base pairs [15].
Figure 2. Linked thioredoxin-glutathione systems, (a) Comparison of thioredoxin, 
glutathione and linked thioredoxin-glutathione systems. The glutathione system com-
prises (i) GR, GSH and Grx, whereas the thioredoxin system consists of (ii) TR and 
Trx. In linked Trx-GSH systems (iii), TGR functionally replaces TR, GR and Grx, pro-
viding reducing equivalents to targets of both systems. In all systems, NADPH is the 
upstream donor of reducing equivalents. (b) Components of the thioredoxin and gluta-
thione systems. Redox centers of GR, TR, TGR, Grx and Trx are indicated, as well as 
the FAD prosthetic group and the ligands NADPH and GSH. TR and TGR possess a 
C-terminal extension missing in GR, which contains the C-terminal GCUG redox-ac-
tive motif. TGR possesses an N-terminal Grx domain that is absent in TR and GR. The 
Grx and Trx domains contain the CXXC redox center. Grx, unlike Trx, binds GSH. (c) 
Schematic representation of electron fl ow in TGR. TGR, like GR and TR, is a homodi-
mer, with monomers oriented in a head-to-tail manner. Electrons fl ow from NADPH to 
FAD, to the CX4C redox center, to the C-terminal GCUG redox center of the second 
subunit, to the CX2C redox center of the Grx domain of the fi rst subunit, and to targets, 
including GSSG (left scheme). Alternatively, electrons can fl ow, presumably directly, 
from the GCUG redox center to Trx (right scheme). The model proposes a fl exible 
hinge, which connects the TR and Grx domains. This organization allows electrons to 
fl ow to the ‘in built’ Grx domain or to Trx. Parts (a) and (b) in the fi gure reprinted with 
modifi cations from [11] with copyright with permission from Elsevier.
364 SA L I N A S,  LO B A N O V,  & GL A D Y S H E V I N  SE L E N I U M  (2006) SE L E N O P R O T E I N S  I N  PA R A S I T E S  365
Selenoproteins of protozoan parasites: waiting for surprises?
Very little is known about selenoproteins from protozoan parasites. Re-
cently, the presence of tRNASec was described in several species of the phy-
lum Apicomplexa [24] (Lobanov et al., submitted). Plasmodium falciparum, 
which is the causative agent of malaria—the most overwhelming human par-
asitic infection, belongs to this phylum. The fi nding of tRNASec was consis-
tent with the presence of putative EFsec and selenophosphate synthetase in P. 
falciparum and other Plasmodia. In addition, tRNASec was observed in Toxo-
plasma, but not in Cryptosporidium parasites. Genome-wide searches for SE-
CIS elements in the six Plasmodium genomes revealed four selenoprotein 
genes. Interestingly, homology analyses of these proteins identifi ed no hits 
outside Apicomplexa, suggesting that these selenoproteins do not exist in the 
apicomplexan hosts. These properties make the new selenoproteins attractive 
targets for anti-malaria drug development.
The other reference in the literature to a parasite Sec-decoding protozoan 
is the description of a Cys-containing selenophosphate synthetase from Leish-
mania major [25]. Leishmania belongs to trypanosomatidae family, which 
also includes Trypanosoma brucei, and T. cruzi (Table 1), which are causative 
agents of disabling and fatal diseases in the poorest rural population of the 
third world [26]. Consistent with the fi nding of selenophosphate synthetase, 
recent bioinformatics analyses revealed three selenoprotein genes in several 
Trypanosoma genomes (Lobanov and Gladyshev, unpublished).
Finally, no single reference could be found in the literature regarding a 
Sec-decoding amoebae, a traditional group of protozoa that include the para-
sitic amoebae of humans, Entamoebae histolytica.
Parasite selenoproteins: drug or vaccine candidates?
From a global perspective, the control of parasitic infections, which are a ma-
jor cause of disability and mortality in many developing countries, remains as 
one of the most important challenges for medicine in the 21st century [2]. Al-
though there are safe and effective drugs to control some parasitic diseases, 
parasites can develop resistance to drugs rendering them ineffective, as it has 
been the case of certain antimalarial drugs [27]. Thus, effective vaccines and 
new drugs against parasitic organisms are needed. The task ahead is enormous 
considering that parasite and hosts are eukaryotic organisms; as yet, there is 
not a single vaccine for a human parasitic infection. Whether selenoproteins 
can be drug targets or generate immunity depends on premises that are not 
necessarily different from those for any other target protein: the validity of a 
drug target would rely on it being an essential protein, and suffi ciently differ-
ent from the host homolog(s) as to be selectively inhibited. Likewise, a good 
vaccine candidate should generate an appropriate and selective immune re-
sponse against the parasite, without inducing pathology to the host.
In platyhelminths, TGR is an attractive pharmacological target because 
of the lack of redundant mechanisms (i.e., TR and GR) to provide reducing 
equivalents to essential enzymes. Inhibition of this enzyme could lead to im-
paired synthesis of DNA and antioxidant defenses, compromising parasite 
survival. TGR may also be a good vaccine candidate, since it is a large protein 
with a degree of identity to host enzymes below 60%. However, there are no 
studies regarding TGR as an immunogen. Contrary to TGR, there are promis-
ing studies on the use of GPx as a vaccine candidate. Vaccination of mice (not 
a natural host) against the platyhelminth S. mansoni with naked DNA con-
structs containing Sec-containing GPx showed signifi cant levels of protection 
compared to a control group [28]. In this context, it is important to empha-
size not only the fact that GPx appears to be important at the host parasite in-
terface, but also that platyhelminth lack catalase and rely exclusively on GSH 
and Trx peroxidases for hydrogen peroxide removal.
In the case of protozoan parasites, further studies are needed to identify 
and functionally characterize their selenoproteins. Nevertheless, it is highly 
signifi cant that the four selenoproteins identifi ed in Plasmodium sp have 
neither Sec nor Cys homologs in humans. Considering that Sec is usually 
located at the redox-active sites of enzymes, the selenol- and thiol-based re-
dox systems may play vital an important role in the survival of protozoan 
parasites [29].
Finally, selenoproteins may be different to other proteins in one respect: 
electrophilic drugs, such as gold or platinum compounds, or alkylating agents 
that react preferentially with Sec over Cys may affect the parasite and the host 
to a different extent, depending on the relative importance of selenoproteins 
for the two organisms, and the presence/absence of Cys-containing enzymatic 
back up systems.
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